Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
tingling in lips; Nerve pain in teeth; swelling; Hives; This non-serious case was reported by a consumer and described the occurrence of tingling lips in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 11-JAN-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced tingling lips (Verbatim: tingling in lips), nerve pain (Verbatim: Nerve pain in teeth), swelling (Verbatim: swelling) and hives (Verbatim: Hives). The outcome of the tingling lips was not resolved and the outcome of the nerve pain, swelling and hives were resolved with sequelae. It was unknown if the reporter considered the tingling lips, nerve pain, swelling and hives to be related to Shingrix. It was unknown if the company considered the tingling lips, nerve pain, swelling and hives to be related to Shingrix. Additional Information: GSK Receipt Date: 14-APR-2025 The patient never reacted to a vaccine - other than COVID before. It was reported that the patient was really looking for someone to tell if she should get the second shot. The patient didn't want shingles but She was 3 months out from first shot and was still tingly in her lips. (Nerve pain in teeth, tingling in lips and swelling, hives) Were the symptoms treated was reported as no Other Products were reported as no